Open House Originale Rabattverträge 2025-31 - Doravirin
Original notice title
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-31 - Doravirin
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated contract value, discount rates, or volume commitments. Financial attractiveness unknown.
Contract ends automatically upon patent expiry; if Doravirin patent expires before 30.11.2027, the contract terminates...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Nov 2027
- Supply of Doravirin pharmaceutical products under discount contracts (Rabattverträge) according to § 130c SGB V.
- Open House procedure – any eligible pharmaceutical undertaker may join during the contract term.
Show full summary
Open House procedure by Techniker Krankenkasse to conclude discount contracts for the active substance Doravirin. No competition; any eligible pharmaceutical undertaker can join during the contract term (max 24 months, ending 30.11.2027). No estimated value available. No procurement documents analyzed beyond the notice. Notably, the structured data indicates EU funding while the XML notice states no EU funding.
Risks
No estimated contract value, discount rates, or volume commitments. Financial attractiveness unknown.
Contract ends automatically upon patent expiry; if Doravirin patent expires before 30.11.2027, the contract terminates...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical undertaker (pharmazeutischer Unternehmer) as per § 4 Abs. 18 AMG for the offered medicinal product.
- Must have valid marketing authorization for Doravirin in Germany or be entitled to place the product on the market.
Eligibility
- Must submit a self-declaration (Anlage 4) confirming eligibility and reliability.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Originale Rabattverträge 2025-31 - Doravirin
Discount contracts for Doravirin. The TK aims to conclude contracts with all suitable pharmaceutical undertakers. No individual negotiations, uniform conditions, non-exclusive. Max 24 months from 01.12.2025 to 30.11.2027. Early termination upon patent expiry.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria
this is an Open House procedure with no selection decision.
Value note
Show original TED data
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zum Wirkstoff Doravirin zu schließen.
Procurement Details
- Publication date
- 12 Oct 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 669486-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated contract value, discount rates, or volume commitments. Financial attractiveness unknown.
Contract ends automatically upon patent expiry; if Doravirin patent expires before 30.11.2027, the contract terminates...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications